![](/img/cover-not-exists.png)
PCN127 COST-EFFECTIVENESS ANALYSIS OF NIVOLUMAB IN COMBINATION WITH IPILIMUMAB COMPARED WITH CURRENTLY AVAILABLE FIRST-LINE TREATMENTS IN PATIENTS WITH PREVIOUSLY UNTREATED METASTATIC RENAL CELL CARCINOMA IN THE UNITED STATES
Tanova, N., Yang, S., Cheung, L.H., Genestier, V., Gooden, K.M., Malcolm, B., Rao, S., Choueiri, T.K.Volume:
22
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.04.251
Date:
May, 2019
File:
PDF, 322 KB
english, 2019